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1. Introduction 
The non-ribosomal synthesis of the dodecapeptide 
bacitracin in a cell free system has been reported by 
Ishihara et al., Simlot et al., and Frbyshov and Laland 
[l-3]. These experiments [3,4] indicate that its 
mechanism of synthesis is in principle similar to the 
‘thiotemplate mechanism’ for the synthesis of gramici- 
din S and tyrocidine [S] . The amino acids are activated 
through the formation of aminoacyladenylates and then 
transferred to thioester sites before polymerization on 
the enzyme. Ishihara and Shimura have demonstrated 
the presence of two enzymes [4] , which activate the 
amino acids in the linear and the cyclic part of baci- 
tracin respectively. Frdyshov and Laland have demon- 
strated the presence of two enzymes [3]. One of them 
activates all the amino acids in bacitracin except lysine 
and ornithine. These two amino acids from the cyclic 
part of the molecule are activated by the other enzyme. 
Both enzymes are necessary for synthesis of bacitracin. 
In the present work, bacitracin synthetase from Bacillus 
licheniformis ATCC 107 16 was resolved into three 
complementary fractions by affinity chromatography, 
on a column containing L-leucine bound through its 
carboxyl group to the amino group of amino-alkyl- 
Sepharose. The first fraction activates the amino acids 
in the linear part of the molecule. The second activates 
lysine and ornithine, and the third activates isoleucine 
and the remaining amino acids in bacitracin. 
2. Methods and materials 
2.1. Bacitracin synthetase 
The 43-49s satd. (NH4)2S04 fractions prepared 
North-Holland Publishing Company - Amsterdam 
as described by Frbyshov and Laland [3] from 
Bacillus licheniformis ATCC 107 16 were used in the 
experiments. 
2.2. Preparation of column 
The affinity chromatography column (3 X 1.6 cm) 
was prepared from 2 g Sepharose 4-B (Pharmacia Fine 
Chemicals) and 3,3’-diaminodiproplylamine, with L- 
leucine as ligand as described by Pass et al. [6]. The 
elution buffer called buffer B contained 0.05 M 
potassium phosphate, pH 7.5,0.2 mM MgC 12 and 0.1 
mM dithiothreitol. 
2.3. Estimation ofATP-[32P]PP; exchange reaction 
The incubations were carried out at 37°C for 30 
min and the exchange reaction was determined as 
described previously [3] with one exception, the con- 
centrations of L-Asp and L-Glu were 20 pmole/ml in- 
cubation mixture [4]. 
2.4. Estimation of bacitracin synthesis 
The incubations were carried out at 37°C for 15 
min and the amount of bacitracin synthesis was deter- 
mined [3] using thin-layer chromatography and radio- 
autography. 
2.5. Labelled substances and measurement of radio- 
activity 
L-[U-14C] isoleucine and [32P]Na4P207 were ob- 
tained from New England Nuclear Corp., Boston, and 
from The Radiochemical Centre, Amersham. For 
counting a Packard Tri-Carb Liquid Scintillation 
counter or a Frieseke and Hoepfner gas-flow counter 
was used. 
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3. Results 
In the experiments the Sepharose column used con- 
tained as ligand L-leucine, bound through its carboxyl 
group to the 3,3’-diaminodiprophylamine spacer. Leu- 
tine is one of the amino acids in the linear part of baci- 
tracin. When bacitracin synthetase (the 43-49% satd. 
(NH,)* SO4 fraction) was applied to the column, it 
was retained and could be eluted by the addition of 
0.1-0.4 M KC1 to the buffer. All fractions were moni- 
tored for the ATP-[32P] PPi exchange reaction in the 
presence of the amino acids occurring in bacitracin A 
(see fig. 1.). It is seen that all the amino acids (under 
the condition used) are activated in one of the three 
peaks designated A, B and C. Peak A activates L-Ile, 
L-Cys, L-Leu and L-Clu. Peak B activates L-Lys and 
L-Orn. Peak C activates L-Phe, L-His, L-Asp and L-Asn. 
The shoulder found in the L-Ile-dependent exchange 
activity profile (fraction 16 and 17 fig. 1) indicates 
that Peak C also activates L-Ile. The yield of the three 
enzymes after fractionation (as determined by the 
exchange reactions) was 90-100%. All three fractions 
were required for maximal bacitracin synthesis (see 
table l), and a combination of any two fractions was 
less than 25% as active as the three fractions com- 
bined. The L-leucine dependent exchange reaction 
catalyzed by fractions 7-l 1 (see fig. 1) is probably 
due to the presence of leucyl-tRNA synthetase since 
Fraction no. 
Fig. 1. Fractionation of bacitracin synthetase on a Sepharose column using L-leucine as a ligand. 0.25 ml (1.5 mg protein) of the 
43-49% (NH,),SO, fraction obtained from 2.5 g wet cells (0.5 1 culture) was put on a column (3 X 1.6 cm) equilibrated with 
buffer B at 4°C. The column was then eluted with buffer B (60 ml/hr). The volume of the fractions was 6.5 ml. After fraction no. 
2,0.1 M KC1 was added to the buffer. After fraction no. 8, an 0.1-0.4 M linear KC1 gradient in buffer B was used. [” PIPPi-ATP 
exchange activity dependent on the L-amino acids isoleucine (o), cysteine (o), leucine (A), glutamic acid (V), lysine (+) ornithine 
(X), phenylalanine (w), histidine (a), aspartic acid (A), and asparagine (+), was measured in 0.2 ml aliquots of each fraction. Total 
amount of radioactivity in each incubation mixture was 120 000 cpm. The radioactivity (40-50 cpm), measured in control tubes 
(without any amino acid), was subtracted. The exchange activities for isoleucine, cysteine and leucine given in the figure have been 
reduced by a factor of 7 for the purpose of convenience. 
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Table 1 
Requirement for three enzyme fractions 
in bacitracin biosynthesis 
Added fraction Bacitracin synthesis 
(cpm) 
A+B+C 2160 
A+B 450 
A +c 315 
B+C 535 
A 150 
B 210 
C 440 
To the contents of tubes 12-14, 16-17 and 
18-20 (fig. 1) were added 2 mg bovine 
serum albumin each. Solid (NH,), SO, was 
added to 80% saturation and the precipitate 
dissolved in 0.2 ml buffer B. The fractions 
were designated Peak B, C, and A respective- 
ly, Bacitracin formation was measured as 
described with 20 ~1 of Peak A, Peak B and 
Peak C. The bacitracin synthesizing activity 
was measured after 15 min incubation 
using L-[‘4C]isoleucine (100 000 cpm). 
Zero time incubation for all the different 
incubation mixtures was 165-175 cpm. 
leucine was the ligand on the column. No stimulation 
of bacitracin synthesis was achieved by adding concen- 
trated protein from fractions 7-l 1 to the combined 
Peaks A, B, and C (results not shown). 
4. Discussion 
The present results provide good evidence that baci- 
tracin synthetase consists of at least three different 
enzymes. The enzyme present in Peak A (fig. l.), acti- 
vates L-isoleucine, L-cysteine, L-leucine and L-glutamic 
acid. The enzyme present in Peak B activates L-!ysine 
and L-ornithine. The enzyme present in Peak C acti- 
vates L-isoleucine, L-phenylalanine, L-hist idine, L-as- 
partic acid and L-asparagine. Peak C also activates L- 
valine, which is found in position no. 8 from the N- 
terminus in bacitracin B as indicated on fig. 2. (Results 
not shown.) L-Isoleucine in positions no. 1 and 5 is 
probably activated by Peak A since Peak B (the next 
enzyme taking part in the polymerisation?) only 
Ile in bac.A 
Val in bac.B 
LYS 
Fig. 2. Schematic representation of bacitracin synthetase. A, 
B and C are the three peaks coming out of the column which 
are necessary for bacitracin biosynthesis. The amino acids in 
bacitracin A (and B) are numbered l-12 from the N-terminal 
end of the molecule. For further details see text. 
activates L-lysine and L-ornithine. No enzyme with 
single ‘isoleucine activity’ was found. 
It seems likely that enzyme A (Peak A) was re- 
tained by the column because it activates leucine and 
hence shows affinity for the leucine ligand. Enzyme C 
is probably retained because it shows affinity for en- 
zyme A. Enzyme B is probably retained because it 
shows affinity for either enzyme A or C. The presence 
of ATP was not required for binding of the enzymes 
to the column. This is in contrast to what is found for 
gramicidin S synthetase where only a little binding of 
the heavy enzyme took place to the ‘leucine column’ 
in the absence of ATP [6]. By using different substrate 
amino acids as ligands on columns, it should be possi- 
ble to study the interaction and the location of the 
areas on the enzymes in bacitracin synthetase which 
exhibit affinity for each other. 
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